Search Results - "Myskowski, Patricia L"

Refine Results
  1. 1

    Racial Disparities in Mycosis Fungoides/Sézary Syndrome–A Single-Center Observational Study of 292 Patients by Gandham, Ashley R., Geller, Shamir, Dusza, Stephen W., Kupper, Thomas S., Myskowski, Patricia. L.

    Published in Clinical lymphoma, myeloma and leukemia (01-04-2024)
    “…Clinical presentation of Mycosis fungoides/Sézary syndrome (MF/SS) in Black and African American (AA) patients can be heterogeneous with poor survival reported…”
    Get full text
    Journal Article
  2. 2

    Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption by SCOPE, Alon, AGERO, Anna Liza C, DUSZA, Stephen W, MYSKOWSKI, Patricia L, LIEB, Jocelyn A, SALTZ, Leonard, KEMENY, Nancy E, HALPERN, Allan C

    Published in Journal of clinical oncology (01-12-2007)
    “…To evaluate the ability of either oral minocycline, topical tazarotene or both, to reduce or prevent cetuximab-related acneiform rash when administered…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome by Virmani, Pooja, MBBS, MD, Zain, Jasmine, MD, Rosen, Steven T., MD, Myskowski, Patricia L., MD, Querfeld, Christiane, MD, PhD

    Published in Dermatologic clinics (01-10-2015)
    “…Mycosis fungoides (MF) and Sézary syndrome (SS) are common types of primary cutaneous T-cell lymphoma. Early-stage MF has a favorable prognosis and responds…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption by Scope, Alon, MD, Lieb, Jocelyn A., MD, Dusza, Stephen W., MPH, Phelan, Deborah L., RN, Myskowski, Patricia L., MD, Saltz, Leonard, MD, Halpern, Allan C., MD, MS

    “…Background Clinical trials addressing the acneiform rash associated with epidermal growth factor receptor inhibitors are lacking. Objective We evaluated the…”
    Get full text
    Journal Article
  9. 9

    Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers by Jawed, Sarah I, Myskowski, Patricia L, Horwitz, Steven, Moskowitz, Alison, Querfeld, Christiane

    “…Mycosis fungoides (MF) and Sézary syndrome (SS) comprise approximately 53% of cutaneous lymphomas. Both MF and SS may clinically and histologically mimic…”
    Get full text
    Journal Article
  10. 10

    Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors by Balagula, Yevgeniy, Garbe, Claus, Myskowski, Patricia L., Hauschild, Axel, Rapoport, Bernardo L., Boers-Doets, Christine B., Lacouture, Mario E.

    Published in International journal of dermatology (01-02-2011)
    “…The last decade in oncology has been highlighted by the emergence of novel, highly specific anti‐cancer agents, targeting a variety of molecular structures and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions by Jawed, Sarah I, Myskowski, Patricia L, Horwitz, Steven, Moskowitz, Alison, Querfeld, Christiane

    “…Both mycosis fungoides (MF) and Sézary syndrome (SS) have a chronic, relapsing course, with patients frequently undergoing multiple, consecutive therapies…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study by Geller, Shamir, Gomez, Christian J., Myskowski, Patricia L., Pulitzer, Melissa

    “…Follicular mucinosis (FM), which is defined by mucin accumulation within follicular epithelium, may occur in mycosis fungoides (MF). FM without MF is…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20